Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
PLX > SEC Filings for PLX > Form 8-K on 13-Aug-2012All Recent SEC Filings

Show all filings for PROTALIX BIOTHERAPEUTICS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for PROTALIX BIOTHERAPEUTICS, INC.

13-Aug-2012

Other Events


Item 8.01. Other Events

On August 13, 2012, Protalix BioTherapeutics, Inc. (the "Company") issued a press release announcing that it has received clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration to initiate clinical trials of PRX-102. The Company plans to commence enrollment of Fabry disease patients for a phase I/II trial in the fourth quarter of 2012.

A copy of the press release is filed as Exhibit 99.1.

  Add PLX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PLX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.